Sigma and CWG Merger Risks and Management Overview slide image

Sigma and CWG Merger Risks and Management Overview

NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES A Highly Attractive Financial Profile $7.9bn FY23 Total Network Sales³ Retail Network 1,2 10% last 5 years' Total Network Sales CAGR³,4 12% FY23 LFL sales growth in Australia5 $3.1bn Revenue CWG (FY23)6,7 $555m EBITDA $460m EBIT Commentary Retail Network factors that drive demand for goods and services from CWG: Trading performance of the Retail Network . Supporting franchisees to grow the Retail Network in Australia Other key drivers of growth for CWG include: • New store roll-out in existing and new international markets Increased penetration of own, private label, licensed and exclusive brands • Improving margins through operating efficiencies and cost discipline 15% EBIT margin FY24 YTD key highlights ✓ Total Network Sales growth of ~15% vs the prior corresponding period 4 Chemist Warehouse stores and 1 new Optometrist Warehouse opened in Australia alongside 7 new Chemist Warehouse stores internationally. 1 pipeline store added to Australian store network Entered into two new supply arrangements (including Sigma supply agreement), with benefits expected to be realised from FY25 23 Notes: 1. The "Retail Network" includes a combination of franchised stores in Australia and wholly and part owned stores across New Zealand, China and Ireland. All Chemist Warehouse and My Chemist pharmacies are franchised in Australia. 2. Chemist Warehouse Group management figures. 3. Total Network Sales includes a combination of the Retail Network's in-store and CWG's online sales. Australian Network Sales and New Zealand Network Sales are not consolidated into CWG revenue. 4. Period from FY18-23. 5. LFL sales comparison of Australian Retail Network stores only (for stores open for at least 12 months). 6. Refer to page 20 for an overview of the business activities undertaken by CWG. 7. Represents CWG's audited statutory financials. Earnings before interest and tax (EBIT) and earnings before interest, tax, depreciation and amortisation (EBITDA) are non IFRS measures of financial performance and have been derived with reference to CWG's audited statutory accounts. 8. Period from 1 July to 31 October 2023 vs same period in 2022. 9. Period from 1 July to 25 November 2023
View entire presentation